Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

NCT04150341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: TD-8236
DRUG: Placebo

Sponsor

Theravance Biopharma